Periscope Capital’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Periscope Capital’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-971,546	Closed	-$10.1M	–	771
2023 Q1	$10.1M	Buy	971,546 +201,031	+26%	+$2.08M	0.47%	72
2022 Q4	$7.91M	Buy	770,515 +258,241	+50%	+$2.61M	0.34%	88
2022 Q3	$5.15M	Buy	512,274 +111,074	+28%	+$1.11M	0.15%	272
2022 Q2	$4M	Sell	401,200 -100	-0%	-$999	0.11%	379
2022 Q1	$4M	Buy	+401,300	New	+$3.98M	0.1%	397

Periscope Capital's LVAC Position: Q2 2023 in Review

Periscope Capital sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 971,546 shares — an estimated $10.1M sold.

Periscope Capital first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $10.1M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Periscope Capital reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Periscope Capital sold 971,546 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $10.1M.
Periscope Capital first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Periscope Capital's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $10.1M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Periscope Capital's 13F filing for Q2 2023, filed 14 Aug 2023.